| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | +5.28% | -1.72% | +7.00% | +7.00% | — |
| 14d | 2 | +0.00% | +17.06% | -1.10% | +18.16% | +18.16% | — |
| 30d | 2 | +50.00% | +1.85% | -2.02% | +3.87% | +3.87% | — |
| 60d | 2 | +50.00% | -11.08% | +2.85% | -13.94% | -13.94% | — |
| 90d | 2 | +50.00% | -9.30% | +1.90% | -21.04% | -21.04% | — |
| 180d | 2(1 pending) | +100.00% | -17.90% | -2.09% | -15.81% | -15.81% | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VYGR VOYAGER THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,668 | $3.77 | $17.6K | 151,416 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| VYGR VOYAGER THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,500 | — | — | 150,500 | Feb 6, 2026 | Feb 10, 2026 ↗ | View → |
| VYGR VOYAGER THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 32,250 | — | — | 156,084 | Feb 6, 2026 | Feb 10, 2026 ↗ | View → |
| VYGR VOYAGER THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 7,666 | $4.78 | $36.6K | 123,834 | Oct 3, 2025 | Oct 7, 2025 ↗ | View → |
| VYGR VOYAGER THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 103,000 | — | — | 103,000 | Feb 21, 2025 | Feb 24, 2025 ↗ | View → |
| VYGR VOYAGER THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 51,500 | — | — | 131,500 | Feb 21, 2025 | Feb 24, 2025 ↗ | View → |
| VYGR VOYAGER THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Oct 1, 2024 | Oct 2, 2024 ↗ | View → |
| VYGR VOYAGER THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Jul 8, 2024 | Jul 9, 2024 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE CHIEF FINANCIAL OFFICER | 834 | $1.75 | $1.5K | 189,403 | May 6, 2024 | May 7, 2024 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE CHIEF FINANCIAL OFFICER | 917 | $1.77 | $1.6K | 190,237 | May 1, 2024 | May 3, 2024 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE CHIEF FINANCIAL OFFICER | 6,310 | $2.27 | $14.3K | 191,154 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE CHIEF FINANCIAL OFFICER | 985 | $2.32 | $2.3K | 197,464 | Feb 6, 2024 | Feb 8, 2024 ↗ | View → |
| VOR VOR BIOPHARMA INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 198,449 | Jan 29, 2024 | Jan 31, 2024 ↗ | View → |
| VOR VOR BIOPHARMA INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 29, 2024 | Jan 31, 2024 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE Chief Financial Officer | 834 | $1.82 | $1.5K | 145,647 | Nov 6, 2023 | Nov 8, 2023 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE Chief Financial Officer | 6,310 | $2.67 | $16.8K | 146,481 | Sep 1, 2023 | Sep 6, 2023 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE Chief Financial Officer | 834 | $2.67 | $2.2K | 152,791 | Aug 7, 2023 | Aug 9, 2023 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE Chief Financial Officer | 834 | $4.14 | $3.5K | 153,625 | May 8, 2023 | May 10, 2023 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE Chief Financial Officer | 6,310 | $5.51 | $34.8K | 154,459 | Mar 1, 2023 | Mar 2, 2023 ↗ | View → |
| VOR VOR BIOPHARMA INC. | PURCHASEGRANT Stock grant | 45,500 | — | — | 160,769 | Feb 6, 2023 | Feb 8, 2023 ↗ | View → |
| VOR VOR BIOPHARMA INC. | PURCHASEGRANT Stock grant | 91,000 | — | — | 91,000 | Feb 6, 2023 | Feb 8, 2023 ↗ | View → |
| VOR VOR BIOPHARMA INC. | PURCHASEGRANT Stock grant | 86,000 | — | — | 115,269 | Sep 1, 2022 | Sep 6, 2022 ↗ | View → |
| VOR VOR BIOPHARMA INC. | PURCHASEGRANT Stock grant | 86,000 | — | — | 86,000 | Sep 1, 2022 | Sep 6, 2022 ↗ | View → |
| VOR VOR BIOPHARMA INC. | PURCHASEGRANT Stock grant | 135,000 | — | — | 135,000 | Feb 1, 2022 | Feb 3, 2022 ↗ | View → |
| VOR VOR BIOPHARMA INC. | SALE Chief Financial Officer | 48,076 | — | — | 0 | Feb 9, 2021 | Feb 9, 2021 ↗ | View → |
| VOR VOR BIOPHARMA INC. | PURCHASE Chief Financial Officer | 3,534 | — | — | 29,269 | Feb 9, 2021 | Feb 9, 2021 ↗ | View → |